Published in J Gen Virol on September 01, 2008
A newly identified bocavirus species in human stool. J Infect Dis (2009) 3.25
Novel human parvovirus 4 genotype 3 in infants, Ghana. Emerg Infect Dis (2010) 2.19
High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies. J Infect Dis (2009) 1.78
Acute diarrhea in West African children: diverse enteric viruses and a novel parvovirus genus. J Virol (2012) 1.64
Widespread infection with homologues of human parvoviruses B19, PARV4, and human bocavirus of chimpanzees and gorillas in the wild. J Virol (2010) 1.42
Changing epidemiology of human parvovirus 4 infection in sub-Saharan Africa. Emerg Infect Dis (2010) 1.36
Discovery and genomic characterization of a novel ovine partetravirus and a new genotype of bovine partetravirus. PLoS One (2011) 1.10
Parvovirus 4-like virus in blood products. Emerg Infect Dis (2010) 1.08
High frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo. J Infect Dis (2011) 1.05
Parvovirus B19 infection in human pregnancy. BJOG (2010) 1.02
Parvovirus 4 in blood donors, France. Emerg Infect Dis (2010) 1.00
Human parvovirus PARV4 DNA in tissues from adult individuals: a comparison with human parvovirus B19 (B19V). Virol J (2010) 0.95
Diversity of parvovirus 4-like viruses in humans, chimpanzees, and monkeys in hunter-prey relationships. Emerg Infect Dis (2012) 0.88
PARV4: an emerging tetraparvovirus. PLoS Pathog (2014) 0.87
Complete genome sequences of two isolates of human parvovirus 4 from patients with acute encephalitis syndrome. Genome Announc (2015) 0.85
Human Parvoviruses. Clin Microbiol Rev (2017) 0.84
Human parvovirus 4 in nasal and fecal specimens from children, Ghana. Emerg Infect Dis (2012) 0.81
Porcine hokovirus in domestic pigs, Cameroon. Emerg Infect Dis (2013) 0.78
Human parvovirus 4 in the blood supply and transmission by pooled plasma-derived clotting factors: does it matter? Transfusion (2012) 0.78
Human parvovirus 4 'PARV4' remains elusive despite a decade of study. F1000Res (2017) 0.77
Human Parvovirus B19 and blood product safety: a tale of twenty years of improvements. Blood Transfus (2015) 0.76
No evidence of presence of parvovirus 4 in a Swedish cohort of severely immunocompromised children and adults. PLoS One (2012) 0.76
PARV4 prevalence, phylogeny, immunology and coinfection with HIV, HBV and HCV in a multicentre African cohort. Wellcome Open Res (2017) 0.75
Disseminated Penicillium marneffei infection in an HIV-positive Italian patient and a review of cases reported outside endemic regions. J Travel Med (2006) 2.30
Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science (2002) 1.97
A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis. Clin Infect Dis (2006) 1.64
A novel diagnostic target in the hepatitis C virus genome. PLoS Med (2009) 1.52
Human parvovirus 4 in the bone marrow of Italian patients with AIDS. AIDS (2007) 1.48
Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study. Antimicrob Agents Chemother (2009) 1.40
Resolution of multidrug-refractory oesophageal candidiasis in an AIDS patient after treatment with caspofungin. AIDS (2002) 1.37
Leishmaniasis among organ transplant recipients. Lancet Infect Dis (2008) 1.29
Thrombotic microangiopathy in patients with acquired immunodeficiency syndrome before and during the era of introduction of highly active antiretroviral therapy. Clin Infect Dis (2002) 1.17
Polymerase chain reaction in the diagnosis and prognosis of Mediterranean visceral leishmaniasis in immunocompetent children. Pediatrics (2002) 1.17
Histoplasmosis among human immunodeficiency virus-infected people in Europe: report of 4 cases and review of the literature. Medicine (Baltimore) (2006) 1.15
Trends in the postmortem diagnosis of opportunistic invasive fungal infections in patients with AIDS: a retrospective study of 1,630 autopsies performed between 1984 and 2002. Am J Clin Pathol (2009) 1.03
Epstein-Barr virus reactivation in a patient treated with anti-thymocyte globulin for severe aplastic anemia. Am J Hematol (2006) 1.03
Aspergillus meningitis: a rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases. J Infect (2012) 1.02
The role of cryptococcal antigen assay in diagnosis and monitoring of cryptococcal meningitis. J Clin Microbiol (2005) 1.01
Prospective observational study of fever in hospitalized returning travelers and migrants from tropical areas, 1997-2001. J Travel Med (2005) 1.00
Clarithromycin versus azithromycin in the treatment of Mediterranean spotted fever in children: a randomized controlled trial. Clin Infect Dis (2001) 1.00
Imported Loa loa filariasis: three cases and a review of cases reported in non-endemic countries in the past 25 years. Int J Infect Dis (2012) 0.98
Reversible posterior leukoencephalopathy syndrome in 2 HIV-infected patients receiving antiretroviral therapy. Clin Infect Dis (2008) 0.97
Failure to eradicate HIV despite fully successful HAART initiated in the first days of life. J Pediatr (2006) 0.96
What is new in esophageal injury (infection, drug-induced, caustic, stricture, perforation)? Curr Opin Gastroenterol (2009) 0.93
Radiculoneuropathy associated with acute hepatitis E. Dig Liver Dis (2013) 0.92
Disseminated microsporidiosis caused by Encephalitozoon cuniculi III (dog type) in an Italian AIDS patient: a retrospective study. Mod Pathol (2002) 0.92
Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study. Clin Infect Dis (2004) 0.90
Plasmodium knowlesi: the emerging zoonotic malaria parasite. Acta Trop (2012) 0.90
Intestinal lymphangiectasia and reversible high liver stiffness. Hepatology (2014) 0.89
Acute parvovirus B19 infection and anemia during Plasmodium falciparum malaria. Clin Infect Dis (2002) 0.89
HIV and direct damage of organs: disease spectrum before and during the highly active antiretroviral therapy era. AIDS (2003) 0.88
Liver-related factors associated with low vitamin D levels in HIV and HIV/HCV coinfected patients and comparison to general population. Curr HIV Res (2011) 0.88
Fluvastatin as an adjuvant to pegylated interferon and ribavirin in HIV/hepatitis C virus genotype 1 co-infected patients: an open-label randomized controlled study. J Antimicrob Chemother (2010) 0.88
Trends and predictors of non-AIDS-defining cancers in men and women with HIV infection: a single-institution retrospective study before and after the introduction of HAART. J Acquir Immune Defic Syndr (2013) 0.87
Noncirrhotic portal hypertension in HIV-infected patients: a case control evaluation and review of the literature. AIDS Patient Care STDS (2010) 0.86
Is real-time polymerase chain reaction (PCR) more useful than a conventional PCR for the clinical management of leishmaniasis? Am J Trop Med Hyg (2009) 0.86
ADAMTS 13 genotype and vWF protease activity in an Italian family with TTP. Thromb Haemost (2003) 0.85
Short communication: impact of hepatitis C viral clearance on CD4+ T-lymphocyte course in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin. AIDS Res Hum Retroviruses (2012) 0.85
Safety of statin therapy in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr (2007) 0.85
[13C]Methionine breath test: a novel method to detect antiretroviral drug-related mitochondrial toxicity. J Antimicrob Chemother (2004) 0.85
Effect of a monoclonal antibody to PCSK9 on LDL cholesterol. N Engl J Med (2012) 0.84
A 6 day course of liposomal amphotericin B in the treatment of infantile visceral leishmaniasis: the Italian experience. J Antimicrob Chemother (2004) 0.82
What is new in esophageal injury (infection, drug-induced, caustic, stricture, perforation)? Curr Opin Gastroenterol (2009) 0.82
Severe Plasmodium vivax malaria: fact or fiction? Clin Infect Dis (2012) 0.82
Biology of human malaria plasmodia including Plasmodium knowlesi. Mediterr J Hematol Infect Dis (2012) 0.82
Changes in the incidence of severe thrombocytopenia and its predisposing conditions in HIV-infected patients since the introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2014) 0.81
Thrombocytopenia and Plasmodium vivax malaria. Clin Infect Dis (2005) 0.81
Diagnosis and therapy for hospitalized imported malaria in adults in Italy. J Travel Med (2011) 0.80
Effect of antioxidants on mitochondrial function in HIV-1-related lipoatrophy: a pilot study. AIDS Res Hum Retroviruses (2010) 0.80
Usefulness of serial determination of Aspergillus galactomannan in the diagnosis and management of invasive aspergillosis in an AIDS patient with non-Hodgkin lymphoma. Mycoses (2011) 0.80
Profile of infective endocarditis observed from 2003 - 2010 in a single center in Italy. BMC Infect Dis (2013) 0.79
Chronic coinfection with hepatitis B and hepatitis C viruses in an Italian population of HIV-infected patients. J Acquir Immune Defic Syndr (2007) 0.79
Candidaemia observed at a university hospital in Milan (northern Italy) and review of published studies from 2010 to 2014. Mycopathologia (2014) 0.78
Visceral leishmaniasis during pegylated interferon therapy for chronic hepatitis C: first report. Antivir Ther (2005) 0.78
Gastrointestinal cancers reactive for the PAb416 antibody against JCV/SV40 T-Ag lack JCV DNA sequences while showing a distinctive pathologic profile. J Clin Pathol (2012) 0.78
Nongastroesophageal reflux disease-related infectious, inflammatory and injurious disorders of the esophagus. Curr Opin Gastroenterol (2007) 0.78
Cryptococcosis: we should do better! Clin Infect Dis (2006) 0.77
13C-Methionine breath test detects liver mitochondrial impairment in HIV-infected patients with antiretroviral drug-related hyperlactatemia. J Acquir Immune Defic Syndr (2004) 0.77
Antibodies are forever: a study using 12-26-year-old expired antibodies. Histopathology (2013) 0.77
Is switching protease inhibitor-based effective antiretroviral therapy safe in patients with AIDS-associated Kaposi's sarcoma? AIDS (2004) 0.77
Epidemiology of bacterial meningitis in Lombardy Region in the period 2000-2006. New Microbiol (2007) 0.77
The good and evil of flare: flares in hepatitis B virus chronic hepatitis. Eur J Gastroenterol Hepatol (2007) 0.76
Fatal septic shock due to Gemella morbillorum in two HIV-positive patients. Clin Microbiol Infect (1996) 0.76
Plasmodium knowlesi: An Overlooked Italian Discovery? Clin Infect Dis (2011) 0.76
Molluscum or a mimic? Add Penicillium marneffei! Am J Med (2007) 0.75
Rapid virological response: is it four or eight weeks? Hepatology (2012) 0.75
Regarding: "influenza-like illness as an atypical presentation of falciparum malaria in a traveler from Africa". J Emerg Med (2011) 0.75
Case 2-2011: a woman with shock after treatment of a furuncle. N Engl J Med (2011) 0.75
Visceral leishmaniasis as a cause of anemia in HIV-infected patients. Clin Infect Dis (2004) 0.75
STAT-C: a full revolution or just a step forward? Lancet (2010) 0.75
KSHV reactivation in post-transplant Kaposi sarcoma. Nat Med (2003) 0.75
A 57-year-old man with a 6-day headache and fatigue. Am J Med (2005) 0.75
Hepatitis B virus infection. N Engl J Med (2009) 0.75
Case 11-2008: Mental-status changes after liver transplantation. N Engl J Med (2008) 0.75